Table 2.
Endothelial function factors in different treatment groups (mean ± SD)a.
| Swimming (min) | CPSM (mg kg−1) | t-PA (pg ml−1) | PAI-1 (pg ml−1) | ET-1 (pg ml−1) | 6-Keto-PGFIα (pg ml−1) | TXB2 (pg ml−1) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sham-operated | 11542.91 ± 1532.31 | 34769.83 ± 1323.89 | 65.79 ± 7.12 | 147.14 ± 13.98 | 64.17 ± 7.15 | ||||||
| 0 | 0 | 5829.23 ± 838.39 | 64492.85 ± 6468.98 | 166.96 ± 22.15 | 57.75 ± 6.32 | 158.27 ± 21.50 | |||||
| 0 | 237 | 8223.36 ± 908.86 | 48827.80 ± 4452.26 | 134.53 ± 6.19 | 81.47 ± 9.03 | 142.68 ± 11.46 | |||||
| 0 | 474 | 8769.49 ± 637.01 | 44455.57 ± 2621.27 | 129.64 ± 6.55 | 88.44 ± 8.86 | 133.88 ± 10.80 | |||||
| 20 | 0 | 7874.40 ± 1076.80 | 53255.25 ± 3832.51 | 143.47 ± 6.41 | 129.04 ± 8.02 | 149.53 ± 9.18 | |||||
| 20 | 237 | 9455.80 ± 437.15 | 44569.45 ± 928.96 | 128.47 ± 7.16 | 105.12 ± 9.70 | 133.68 ± 12.58 | |||||
| 20 | 474 | 9884.82 ± 219.63 | 42775.73 ± 1818.98 | 112.54 ± 13.72 | 123.58 ± 14.04 | 113.59 ± 5.23 | |||||
| 40 | 0 | 9210.72 ± 271.99 | 49138.89 ± 1532.58 | 138.18 ± 6.99 | 142.87 ± 9.60 | 140.79 ± 8.49 | |||||
| 40 | 237 | 10087.91 ± 435.67 | 40662.67 ± 3043.49 | 100.08 ± 10.51 | 125.53 ± 5.19 | 94.12 ± 7.44 | |||||
| 40 | 474 | 11042.35 ± 587.88 | 38285.89 ± 2814.35 | 90.46 ± 11.61 | 132.41 ± 3.60 | 82.15 ± 12.41 | |||||
| Two-way ANOVA | F | p | F | p | F | p | F | p | F | p | |
| Swimming | 77.30 | <0.001 | 42.70 | <0.001 | 46.68 | <0.001 | 259.43 | <0.001 | 58.66 | <0.001 | |
| CPSM | 66.34 | <0.001 | 92.03 | <0.001 | 64.62 | <0.001 | 8.19 | <0.001 | 59.87 | <0.001 | |
| CPSM × swimming | 2.79 | 0.04 | 4.74 | <0.001 | 2.15 | 0.09 | 19.98 | <0.001 | 5.37 | <0.001 | |
a
All data are expressed as the mean ± SD. The GLM procedure was applied for a two-way ANOVA to test for synergy. Comparisons between each pair of factor levels were analyzed using a Bonferroni post hoc test. A value of p < 0.05 was considered statistically significant.